IRIS
PORZIO, Giampiero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.462
AS - Asia 3.022
EU - Europa 2.744
SA - Sud America 494
AF - Africa 64
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.799
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.385
SG - Singapore 1.267
IE - Irlanda 703
CN - Cina 672
RU - Federazione Russa 633
BR - Brasile 418
TR - Turchia 365
DE - Germania 343
HK - Hong Kong 313
VN - Vietnam 231
UA - Ucraina 189
IT - Italia 170
GB - Regno Unito 166
SE - Svezia 147
FI - Finlandia 106
FR - Francia 102
CZ - Repubblica Ceca 43
CA - Canada 40
IN - India 39
NL - Olanda 38
PL - Polonia 35
JP - Giappone 25
MX - Messico 25
BE - Belgio 23
ZA - Sudafrica 22
MA - Marocco 21
BD - Bangladesh 18
AR - Argentina 17
IQ - Iraq 15
EC - Ecuador 12
ES - Italia 11
PK - Pakistan 10
PY - Paraguay 10
UZ - Uzbekistan 10
CO - Colombia 9
PE - Perù 8
TN - Tunisia 8
JO - Giordania 7
VE - Venezuela 7
AU - Australia 6
CL - Cile 6
ID - Indonesia 6
IL - Israele 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
RS - Serbia 5
AT - Austria 4
AZ - Azerbaigian 4
BO - Bolivia 4
EU - Europa 4
JM - Giamaica 4
LT - Lituania 4
NP - Nepal 4
DZ - Algeria 3
NZ - Nuova Zelanda 3
OM - Oman 3
PH - Filippine 3
PT - Portogallo 3
RO - Romania 3
SA - Arabia Saudita 3
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
HN - Honduras 2
HU - Ungheria 2
KR - Corea 2
KZ - Kazakistan 2
MY - Malesia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
CH - Svizzera 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
GY - Guiana 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LY - Libia 1
MC - Monaco 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 11.799
Salva come PNG Salva come JPEG
Città #
Chandler 712
Jacksonville 705
Dublin 703
Singapore 656
Dallas 536
San Jose 534
Ashburn 328
Hong Kong 311
Santa Clara 230
Boardman 225
The Dalles 171
Izmir 156
Ann Arbor 141
Wilmington 113
Nanjing 112
New York 111
Lawrence 102
Princeton 102
Beijing 99
Moscow 89
Ho Chi Minh City 75
San Mateo 72
Los Angeles 64
Munich 60
Columbus 50
Bremen 49
Lauterbourg 49
Dearborn 43
Brno 42
São Paulo 41
Hanoi 40
Shenyang 40
Seattle 39
Nanchang 37
Helsinki 35
Amsterdam 33
Warsaw 31
Milan 29
Woodbridge 27
Jinan 26
L'aquila 25
Tokyo 25
Brussels 23
Frankfurt am Main 23
Montreal 22
Tianjin 22
Des Moines 21
Council Bluffs 20
Hebei 20
Mountain View 20
Atlanta 19
Düsseldorf 19
Kunming 18
London 18
Stockholm 18
Casablanca 17
Johannesburg 17
San Francisco 17
Assago 16
Dong Ket 16
Chennai 15
Denver 15
Hefei 15
Verona 15
Da Nang 14
Norwalk 14
Orem 14
Brooklyn 13
Falkenstein 13
Ningbo 13
Zhengzhou 13
Chicago 12
Guangzhou 12
Haiphong 12
Jiaxing 12
Rome 12
Changsha 11
Shanghai 11
Hải Dương 10
Philadelphia 10
Phoenix 10
Belo Horizonte 9
Brasília 9
Mexico City 9
Nuremberg 9
Rio de Janeiro 9
Tashkent 9
Fortaleza 8
Monza 8
Poplar 8
Querétaro 8
Tappahannock 8
Boston 7
Curitiba 7
Pune 7
Amman 6
Hangzhou 6
Lappeenranta 6
Oklahoma City 6
Taizhou 6
Totale 7.825
Salva come PNG Salva come JPEG
Nome #
The supportive care task force at the University of L'Aquila: 2-years experience 199
Epidemiology and Characteristics of Episodic Breathlessness In Advanced Cancer Patients: An Observational Study 166
Does pain intensity predict a poor opioid response in cancer patients? 165
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study 157
Tapentadol in cancer pain management: a prospective open-label study 148
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 146
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 146
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 144
Efficacy and safety of deep, continuous palliative sedation at home: A retrospective, single-institution study 143
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 142
Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series 141
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index 141
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 140
Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy 134
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 134
Pain evaluation and management: a survey of Italian radiotherapists 133
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice 133
Multimodality treatment in metastatic gastric cancer: From past to next future 132
Safety and Effectiveness of Intravenous Morphine for Episodic Breakthrough Pain in Patients Receiving Transdermal Buprenorphine 131
Efficacy of pregabalin in the management of cetuximab-related itch 130
Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience 129
Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients 129
Age differences in the last week of life in advanced cancer patients followed at home 129
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study 129
What Is Known about Theragnostic Strategies in Colorectal Cancer 128
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors 126
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study 125
Gabapentin in the treatment of severe sweating experienced by advanced cancer patients 125
Integrating oncology and palliative home care in Italy: the experience of the "L'Aquila per la Vita" Home Care Unit 125
The frequency of alcoholism in patients with advanced cancer admitted to an acute palliative care unit and a home care program 125
Assessment and treatment of symptoms among italian medical oncologists 124
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome 124
Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line 123
Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law 123
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 123
The PERSONS score: A new tool for cancer patients' symptom assessment in simultaneous care and home care settings 122
Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases 122
Pain intensity as prognostic factor in cancer pain management 121
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management 121
Switching from Transdermal Drugs: An Observational "N of 1" Study of Fentanyl and Buprenorphine 120
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 120
Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study 120
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience 119
Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With Nivolumab 118
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 118
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians’ practice 117
Can malignant bowel obstruction in advanced cancer patients be treated at home ? 116
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report 116
Palliative sedation in patients with advanced cancer followed at home: A systematic review 114
Dosing fentanyl buccal tablet for breakthrough cancer pain: Dose titration versus proportional doses 113
Breakthrough pain in oncology: A longitudinal study 113
The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study 113
Palliative radiotherapy in advanced cancer patients treated with immune‑checkpoint inhibitors: The PRACTICE study 113
Cancer care after natural disaster: Different countries, similar problems 113
Timed-flat infusion (TFI) 5-fluorouracil with irinotecan and oxaliplatin in pancreatic adenocarcinomas: A single institution experience with FIr/FOx regimen 113
Pattern of symptoms and symptomatic treatment in adults and the aged population: A retrospective analysis of advanced cancer patients followed at home 112
Sleep Disturbances in Patients with Advanced Cancer in Different Palliative Care Settings. 111
The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy 111
Choice of chemotherapy schedules in elderly patients (> 75 years) with metastatic colorectal cancer (mcrc) according to comorbidity 111
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids 110
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 110
Validation of the pap score in advanced cancer patients who are candidates for palliative chemotherapy 109
The effects of low doses of pregabalin on morphine analgesia in advanced cancer patients 109
The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting 108
Effective analgesic score: a "marker" of the effects of chemotherapy on pain in advanced cancer patients? 108
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 108
Topical menthol for treatment of chemotherapy-induced peripheral neuropathy 107
Physical Exercise and Quality of Life in Breast Cancer Survivors 106
Palliative care in advanced cancer patients: how and when? And where? 106
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey 103
Tools for Identifying Cancer Pain of Predominantly Neuropathic Origin and Opioid Responsiveness in Cancer Patients 103
Prognostic factors of survival in patients with advanced cancer admitted to home care 103
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study 103
Pain Characteristics and Analgesic Treatment in an Aged Adult Population: A 4-Week Retrospective Analysis of Advanced Cancer Patients Followed at Home. 102
How do cancer patients receiving palliative care at home die? A descriptive study 102
Palliative sedation in advanced cancer patients followed at home: A retrospective analysis 102
Timed-flat infusion of 5-fluorouracil with docetaxel and oxaliplatin as first-line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen 102
Rapid resolution of refractory chemotherapy induced oral mucositis with platelet gel-released supernatant in a pediatric cancer patient: a case report 100
Palliative sedation in patients with advanced cancer followed at home: A prospective study 100
Morphine in the treatment of incident pain triggered by vinorelbine infusion 99
Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies. 99
Home care for cancer patients after an earthquake: the experience of the "L'Aquila per la Vita" Home Care Unit 99
Integration between oncology and palliative care: A plan for the next decade? 97
Orphan symptoms in advanced cancer patients followed at home 96
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 92
Pharmacokinetics in pelvic stop-flow infusion and hypoxic pelvic perfusion with and without hemofiltration. 92
Re. “Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey” 92
Palliative sedation at home: A medical act practicable everywhere 91
Clinical and psychometric validation of the BreSAS questionnaire for symptom assessment among breast cancer survivors 91
Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain 90
Opioids applied topically to painful cutaneous malignant ulcers in a palliative care setting 89
Supporto nutrizionale 88
Topical morphine in the treatment of painful ulcers 87
Is there a role for neurologist in an oncological home care team? 86
Tumori Ginecologici 86
Emergencies in patients with advanced cancer followed at home 85
Opioid switching in patients with advanced cancer followed at home. A retrospective analysis 85
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a web based online survey among Italian experts on supportive care in cancer 85
Pruritus in a patient with advanced cancer successfully treated with continuous infusion of granisetron 83
"palliative" or "supportive": Is It Just a Matter of Word? 79
Totale 11.571
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.888
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.888
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021206 0 0 0 0 0 0 0 0 0 20 156 30
2021/2022469 18 24 46 21 27 6 11 41 36 6 40 193
2022/20232.108 133 151 32 237 192 200 2 137 898 14 61 51
2023/2024452 63 24 22 48 37 114 3 33 1 25 16 66
2024/20252.361 60 35 169 131 356 203 370 173 475 110 165 114
2025/20263.833 225 430 375 512 401 326 617 128 377 442 0 0
Totale 11.911